To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TTYH3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
424 supporting clones for gene TTYH3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DR760253 embryonic stem .a 1 to 709 18 to 726   tiling clone,   709/726
(97 %)
6 diff
(99.2 %id)
BX404566 neuroblastoma .a 15 to 1069 1 to 1045       1045/1045
(100 %)
26 diff
(97.6 %id)
AL521971 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 15 to 725 1 to 705       705/705
(100 %)
26 diff
(96.4 %id)
AL522452 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 15 to 924 1 to 907       907/907
(100 %)
9 diff
(99.1 %id)
NM_025250.2   .a 15 to 4827 1 to 4813 exact RefSeq, AAA   4813/4813
(100 %)
0 diff
(100 %id)
AL530584 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 17 to 1072 1 to 1045       1045/1045
(100 %)
30 diff
(97.2 %id)
AB051478 brain .a 20 to 4834 1 to 4816 exact available from KIAA,   4816/4816
(100 %)
2 diff
(100.0 %id)
BC152447 Clones donated by Kazusa DNA Research Inst. .a 20 to 4827 1 to 4809 exact tiling clone, AAA   4809/4809
(100 %)
2 diff
(100.0 %id)
BX354600 Neuroblastoma Cot 25-normalized .a 26 to 830 1 to 806       806/806
(100 %)
18 diff
(97.8 %id)
BX381219 Placenta Cot 25-normalized .a 49 to 728 36 to 720       685/755
(90 %)
48 diff
(93.7 %id)
CN391530 embryonic stem cells, DMSO-treated H9 cellline .a 53 to 269 1 to 217       217/217
(100 %)
0 diff
(100 %id)
CN391519 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 60 to 467 1 to 409       409/409
(100 %)
2 diff
(99.6 %id)
BM147487 leukopheresis .a 63 to 560 1 to 498       498/498
(100 %)
12 diff
(97.6 %id)
BM194520 leukopheresis .a 63 to 593 1 to 531       531/531
(100 %)
6 diff
(98.9 %id)
BC131824 PCR rescued clones .a 144 to 3539 1 to 3396 exact tiling clone,   3396/3396
(100 %)
0 diff
(100 %id)
AB162931   .a 190 to 4834 1 to 4646 exact     4646/4646
(100 %)
2 diff
(100.0 %id)
AL541050 placenta .a 278 to 1265 1 to 979       979/1002
(97 %)
13 diff
(98.8 %id)
BF738520 bladder_tumor .a 633 to 1105 497 to 21     Submitted on the opposite strand 477/497
(95 %)
8 diff
(98.4 %id)
BG421160 Kidney, renal cell adenocarcinoma .a 750 to 1501 1 to 747       747/940
(79 %)
28 diff
(97.1 %id)
AA077608 brain .a 773 to 1052 1 to 279       279/279
(100 %)
2 diff
(99.3 %id)
BF356146 head_neck .a 896 to 1210 22 to 333       315/348
(90 %)
11 diff
(96.9 %id)
BF356170 head_neck .a 896 to 1210 22 to 333       315/348
(90 %)
11 diff
(96.9 %id)
BM478312 eye, retinoblastoma .a 955 to 1610 1 to 666       666/1201
(55 %)
29 diff
(97.6 %id)
BU553344 ovary, teratocarcinoma, cell line .a 1005 to 1709 1 to 706       706/951
(74 %)
11 diff
(98.9 %id)
BU849054 ovary, teratocarcinoma, cell line .a 1005 to 1857 1 to 876       876/936
(93 %)
17 diff
(98.2 %id)
CN391518 embryonic stem cells, cell lines H1, H7, andH9 .a 1077 to 1297 1 to 221       221/221
(100 %)
0 diff
(100 %id)
CN391516 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1093 to 1760 1 to 668       668/668
(100 %)
2 diff
(99.8 %id)
BU849061 ovary, teratocarcinoma, cell line .a 1112 to 1937 1 to 847       847/861
(98 %)
31 diff
(96.4 %id)
CN484158 eye .a 1142 to 1781 1 to 640       640/640
(100 %)
0 diff
(100 %id)
CN391524 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1171 to 1538 1 to 368       368/368
(100 %)
0 diff
(100 %id)
CN391538 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1181 to 1581 1 to 401       401/401
(100 %)
1 diff
(99.8 %id)
CN391539 embryonic stem cells, cell lines H1, H7, andH9 .a 1246 to 1379 1 to 134       134/134
(100 %)
1 diff
(99.3 %id)
CN391532 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1282 to 1932 1 to 651       651/651
(100 %)
0 diff
(100 %id)
CN391517 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1328 to 1884 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BF952009 nervous_normal .a 1334 to 1701 527 to 159       369/527
(70 %)
5 diff
(99.1 %id)
BI087099 cervix .a 1364 to 1948 1 to 591       591/601
(98 %)
44 diff
(92.7 %id)
AF318350   .a 1370 to 4528 1 to 3157   AAA   3157/3157
(100 %)
16 diff
(99.5 %id)
BQ232730 melanotic melanoma, skin .a 1387 to 1942 1 to 561       561/1012
(55 %)
17 diff
(98.4 %id)
BG338992 leiomyosarcoma cell line, uterus .a 1429 to 2192 1 to 750       750/751
(99 %)
33 diff
(95.7 %id)
BC019028 Uterus, leiomyosarcoma .a 1430 to 2476 10 to 1056   AAA   1047/2653
(39 %)
0 diff
(100 %id)
BF952011 nervous_normal .a 1458 to 1839 388 to 8       381/388
(98 %)
0 diff
(100 %id)
BI035946 nervous_tumor .a 1466 to 1809 1 to 344       344/347
(99 %)
2 diff
(99.5 %id)
BE313226 brain, neuroblastoma .a 1467 to 2116 647 to 1     Submitted on the opposite strand 647/647
(100 %)
8 diff
(98.8 %id)
BM468968 duodenal adenocarcinoma, cell line, small intestine .a 1467 to 2055 128 to 726       599/1271
(47 %)
21 diff
(98.4 %id)
CN391543 embryonic stem cells, DMSO-treated H9 cellline .a 1492 to 1714 11 to 233       223/233
(95 %)
6 diff
(97.5 %id)
AW026705 brain, glioblastoma (pooled) .a 1591 to 2027 437 to 1       437/437
(100 %)
1 diff
(99.8 %id)
BF951998 nervous_normal .a 1600 to 1848 1 to 246       246/247
(99 %)
12 diff
(95.2 %id)
BQ940755 epidermoid carcinoma, cell line, lung .a 1612 to 2548 1 to 941       941/941
(100 %)
9 diff
(99.1 %id)
BU528967 epidermoid carcinoma, cell line, lung .a 1612 to 2348 1 to 748       748/800
(93 %)
14 diff
(98.3 %id)
BF310645 brain, neuroblastoma .a 1623 to 2132 540 to 6     Submitted on the opposite strand 535/1134
(47 %)
12 diff
(99.0 %id)
BF738349 bladder_tumor .a 1647 to 1757 113 to 2     Submitted on the opposite strand 112/113
(99 %)
1 diff
(99.2 %id)
CX165465 human embryonic stem cells differentiated toan early endodermal cell type .a 1659 to 2370 1 to 712       712/712
(100 %)
0 diff
(100 %id)
AW292215   .a 1702 to 2033 339 to 8       332/342
(97 %)
0 diff
(100 %id)
BM556820 duodenal adenocarcinoma, cell line, small intestine .a 1702 to 2543 16 to 866       851/944
(90 %)
16 diff
(98.4 %id)
BF737427 bladder_tumor .a 1709 to 1818 109 to 2     Submitted on the opposite strand 108/109
(99 %)
0 diff
(100 %id)
AL833825 amygdala .a 1720 to 4827 1 to 3108   available from DKFZ, AAA   3108/3108
(100 %)
8 diff
(99.8 %id)
ES308566 beard hair, skin .a 1720 to 1926 1 to 207       207/208
(99 %)
3 diff
(98.6 %id)
CN391521 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1773 to 2044 1 to 272       272/272
(100 %)
1 diff
(99.7 %id)
BQ887759 brain, neuroblastoma, cell line .a 1826 to 2607 1 to 789       789/955
(82 %)
17 diff
(98.3 %id)
BQ219631 epithelioid carcinoma, Pancreas .a 1853 to 2333 1 to 485       485/1074
(45 %)
13 diff
(98.8 %id)
BQ420661 epithelioid carcinoma, Pancreas .a 1891 to 2532 1 to 650       650/935
(69 %)
18 diff
(98.1 %id)
CN391513 embryonic stem cells, cell lines H1, H7, andH9 .a 1900 to 2549 1 to 653       653/653
(100 %)
6 diff
(99.1 %id)
DB478005 hippocampus .a 1938 to 2364 1 to 426       426/431
(98 %)
6 diff
(98.7 %id)
BU931229 ovary, teratocarcinoma, cell line .a 1951 to 2703 1 to 763       763/927
(82 %)
26 diff
(97.2 %id)
BF755830 colon .a 1974 to 2340 68 to 438       371/439
(84 %)
18 diff
(95.9 %id)
DN601895 human embryonic stem cells .a 1984 to 2697 1 to 714       714/714
(100 %)
0 diff
(100 %id)
BF329648 breast_normal .a 1999 to 2299 323 to 21       303/328
(92 %)
0 diff
(100 %id)
BF568541 epithelioid carcinoma cell line, Pancreas .a 2025 to 2645 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
BU633132 cell lines, Chondrosarcoma .a 2034 to 2536 521 to 19   AAA   503/612
(82 %)
1 diff
(99.9 %id)
CN391531 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2048 to 2552 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
BQ421021 epithelioid carcinoma, Pancreas .a 2061 to 2915 1 to 861       861/877
(98 %)
10 diff
(98.9 %id)
TI_44384885   .a 2087 to 2635 44 to 606       563/800
(70 %)
27 diff
(96.7 %id)
AW239033 lung, cell line .a 2152 to 2450 1 to 299       299/299
(100 %)
0 diff
(100 %id)
CN391514 embryonic stem cells, cell lines H1, H7, andH9 .a 2153 to 2753 7 to 606       600/606
(99 %)
6 diff
(99.1 %id)
CN391525 embryonic stem cells, cell lines H1, H7, andH9 .a 2159 to 2385 1 to 227       227/227
(100 %)
2 diff
(99.2 %id)
CN391512 embryonic stem cells, cell lines H1, H7, andH9 .a 2180 to 2804 1 to 626       626/626
(100 %)
3 diff
(99.6 %id)
CN391527 embryonic stem cells, cell lines H1, H7, andH9 .a 2185 to 2787 1 to 603       603/603
(100 %)
0 diff
(100 %id)
BE907251 epithelioid carcinoma, Pancreas .a 2188 to 2642 1 to 455       455/455
(100 %)
2 diff
(99.6 %id)
CX867734 embryonic stem .a 2310 to 3111 1 to 802       802/802
(100 %)
0 diff
(100 %id)
CN391534 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2380 to 2770 5 to 395       391/395
(98 %)
6 diff
(98.5 %id)
BY795327 eye .a 2381 to 2997 1 to 617       617/617
(100 %)
0 diff
(100 %id)
AL118600 amygdala .a 2392 to 2970 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BU855865 ovary, teratocarcinoma, cell line .a 2397 to 3116 1 to 722       722/881
(81 %)
7 diff
(99.3 %id)
BF036697 adenocarcinoma, ovary .a 2403 to 3014 37 to 654       618/1031
(59 %)
27 diff
(97.4 %id)
BE261079 brain, neuroblastoma .a 2438 to 2981 1 to 551       551/551
(100 %)
9 diff
(98.4 %id)
ES307876 beard hair, skin .a 2450 to 2621 1 to 172       172/172
(100 %)
0 diff
(100 %id)
AL522451 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 3829 to 4819 988 to 2       987/988
(99 %)
0 diff
(100 %id)
AL521970 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 4062 to 4631 755 to 182       574/755
(76 %)
0 diff
(100 %id)
CX867658 embryonic stem .a 4182 to 4834 678 to 26   tiling clone, AAA   653/653
(100 %)
3 diff
(99.6 %id)
AL563791 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 4197 to 4801 606 to 1       606/606
(100 %)
8 diff
(98.7 %id)
AW075684 lung, cell line .a 4217 to 4528 322 to 11   AAA   312/313
(99 %)
3 diff
(99.1 %id)
BX329639 Neuroblastoma Cot 25-normalized .a 4337 to 4819 491 to 10       482/619
(77 %)
0 diff
(100 %id)
AL568707 placenta .a 4513 to 4819 307 to 1       307/309
(99 %)
3 diff
(99.1 %id)
AK074158 Spleen .b 1 to 4128 1 to 4127 Q32K S351R tiling clone, available from FLJ,   4127/4127
(100 %)
6 diff
(99.9 %id)
BG419666 Kidney, renal cell adenocarcinoma .b 1852 to 2481 1 to 628       628/632
(99 %)
5 diff
(99.3 %id)
BG424993 Kidney, renal cell adenocarcinoma .b 1852 to 2472 1 to 619       619/630
(98 %)
3 diff
(99.6 %id)
BM555320 amelanotic melanoma, cell line, skin .b 1865 to 2753 24 to 922       899/1046
(85 %)
27 diff
(97.5 %id)
BM912829 amelanotic melanoma, cell line, skin .b 1865 to 2346 18 to 499       482/1435
(33 %)
7 diff
(99.6 %id)
BM561226 amelanotic melanoma, cell line, skin .b 1865 to 2759 1 to 924       924/1143
(80 %)
53 diff
(95.4 %id)
BM915465 amelanotic melanoma, cell line, skin .b 1865 to 2763 26 to 941       916/1100
(83 %)
32 diff
(97.1 %id)
BM912559 amelanotic melanoma, cell line, skin .b 1866 to 2290 1 to 426       426/1340
(31 %)
5 diff
(99.7 %id)
CN391528 embryonic stem cells, DMSO-treated H9 cellline .b 1886 to 2072 1 to 187       187/187
(100 %)
5 diff
(97.4 %id)
BE273330 Kidney, renal cell adenocarcinoma .b 1889 to 2531 1 to 647       647/714
(90 %)
29 diff
(96.0 %id)
BE272740 Kidney, renal cell adenocarcinoma .b 1890 to 2483 1 to 602       602/602
(100 %)
5 diff
(99.2 %id)
BM552523 astrocytoma grade IV, cell line, brain .b 1910 to 2600 3 to 694       692/1051
(65 %)
21 diff
(98.1 %id)
DR761115 embryonic stem .b 1914 to 2688 1 to 775   tiling clone,   775/775
(100 %)
0 diff
(100 %id)
CN391523 embryonic stem cells, cell lines H1, H7, andH9 .b 1915 to 2418 1 to 504       504/504
(100 %)
3 diff
(99.5 %id)
BM045365 carcinoma, cell line, Prostate .b 1917 to 2486 1 to 570       570/570
(100 %)
3 diff
(99.5 %id)
BG764705 melanotic melanoma, high MDR (cell line), skin .b 1934 to 2486 1 to 556       556/556
(100 %)
7 diff
(98.8 %id)
BG764012 melanotic melanoma, high MDR (cell line), skin .b 1935 to 2486 1 to 547       547/547
(100 %)
7 diff
(98.8 %id)
BQ673676 epidermoid carcinoma, cell line, salivary gland .b 1936 to 2502 1 to 565       565/1020
(55 %)
20 diff
(98.1 %id)
BE258309 eye, retinoblastoma .b 1937 to 2463 1 to 534       534/534
(100 %)
10 diff
(98.2 %id)
BE254834 eye, retinoblastoma .b 1942 to 2381 1 to 439       439/439
(100 %)
4 diff
(99.1 %id)
BU500906 eye, normal pigmented retinal epithelium .b 1946 to 2493 1 to 555       555/1129
(49 %)
12 diff
(99.0 %id)
BG748608 eye, normal pigmented retinal epithelium .b 1965 to 2482 1 to 519       519/524
(99 %)
2 diff
(99.7 %id)
CN391536 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1985 to 2467 12 to 495       484/495
(97 %)
6 diff
(98.8 %id)
CN391535 embryonic stem cells, DMSO-treated H9 cellline .b 2009 to 2603 1 to 596       596/596
(100 %)
1 diff
(99.9 %id)
BG170368 hypernephroma, cell line, Kidney .b 2033 to 2622 1 to 613       613/812
(75 %)
37 diff
(95.5 %id)
BI089856 cervix .b 2053 to 2792 8 to 749       742/749
(99 %)
10 diff
(98.7 %id)
BU183311 melanotic melanoma, skin .b 2057 to 2834 1 to 786       786/928
(84 %)
25 diff
(97.4 %id)
CX758644 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 2057 to 2805 36 to 773     Submitted on the opposite strand 738/778
(94 %)
12 diff
(98.5 %id)
BF307129 muscle, rhabdomyosarcoma .b 2070 to 2747 1 to 668       668/728
(91 %)
22 diff
(97.0 %id)
BF309547 muscle, rhabdomyosarcoma .b 2070 to 2486 1 to 415       415/415
(100 %)
2 diff
(99.6 %id)
BF307764 muscle, rhabdomyosarcoma .b 2071 to 2472 1 to 394       394/405
(97 %)
13 diff
(96.8 %id)
BF030924 hypernephroma, Kidney .b 2098 to 2549 1 to 450       450/450
(100 %)
4 diff
(99.2 %id)
BQ711205 Spleen .b 2099 to 2804 1 to 702       702/951
(73 %)
22 diff
(97.7 %id)
CX762822 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 2108 to 2789 1 to 680     Submitted on the opposite strand 680/811
(83 %)
16 diff
(98.1 %id)
BQ638814 eye, retina .b 2138 to 2720 11 to 594       584/594
(98 %)
6 diff
(99.0 %id)
R14752 whole brain .b 2143 to 2499 1 to 357       357/358
(99 %)
6 diff
(98.4 %id)
BC069027 Salivary gland, epidermoid carcinoma .b 2166 to 4121 1 to 1956   AAA   1956/1956
(100 %)
5 diff
(99.8 %id)
BQ671548 epidermoid carcinoma, cell line, salivary gland .b 2167 to 2855 1 to 700       700/947
(73 %)
21 diff
(97.8 %id)
BE731705 choriocarcinoma, placenta .b 2179 to 2466 1 to 286       286/286
(100 %)
2 diff
(99.4 %id)
CN391522 embryonic stem cells, DMSO-treated H9 cellline .b 2188 to 2728 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
BM560909 eye, retinoblastoma .b 2214 to 3072 15 to 880       866/949
(91 %)
21 diff
(97.8 %id)
BQ670099 epidermoid carcinoma, cell line, salivary gland .b 2216 to 2756 1 to 541       541/909
(59 %)
8 diff
(99.2 %id)
BG324951 Kidney, renal cell adenocarcinoma .b 2222 to 2486 1 to 266       266/266
(100 %)
2 diff
(99.3 %id)
BM150063 leukopheresis .b 2227 to 2486 260 to 1       260/279
(93 %)
6 diff
(97.9 %id)
BQ278163 ovary, teratocarcinoma, cell line .b 2231 to 3012 1 to 795       795/1130
(70 %)
22 diff
(98.1 %id)
T09383   .b 2235 to 2535 1 to 300       300/300
(100 %)
3 diff
(99.0 %id)
BM807825 amelanotic melanoma, cell line, skin .b 2235 to 2753 26 to 548   available from MGC,   523/944
(55 %)
12 diff
(98.8 %id)
BM914977 amelanotic melanoma, cell line, skin .b 2235 to 2795 21 to 581       561/1193
(47 %)
13 diff
(99.0 %id)
BM916824 amelanotic melanoma, cell line, skin .b 2235 to 2807 19 to 594       576/1237
(46 %)
13 diff
(99.0 %id)
BM550326 amelanotic melanoma, cell line, skin .b 2236 to 3230 1 to 1011       1011/1075
(94 %)
39 diff
(96.4 %id)
BC041603 Skin, melanoma, amelanotic .b 2236 to 3825 1 to 1590   available from MGC, AAA   1590/1590
(100 %)
1 diff
(100.0 %id)
BM810128 amelanotic melanoma, cell line, skin .b 2237 to 3138 1 to 909       909/1074
(84 %)
39 diff
(96.4 %id)
BM810939 amelanotic melanoma, cell line, skin .b 2237 to 3077 1 to 849       849/1059
(80 %)
22 diff
(98.0 %id)
BM811004 amelanotic melanoma, cell line, skin .b 2237 to 2982 1 to 751       751/1130
(66 %)
20 diff
(98.3 %id)
BM914971 amelanotic melanoma, cell line, skin .b 2237 to 3148 1 to 925       925/1078
(85 %)
30 diff
(97.3 %id)
BM915320 amelanotic melanoma, cell line, skin .b 2237 to 3080 1 to 870       870/1095
(79 %)
27 diff
(97.6 %id)
BM916478 amelanotic melanoma, cell line, skin .b 2237 to 3232 1 to 1014       1014/1089
(93 %)
26 diff
(97.7 %id)
CD674113 eye, lens .b 2238 to 2811 1 to 574       574/574
(100 %)
0 diff
(100 %id)
BG677758 skin, squamous cell carcinoma .b 2279 to 2903 1 to 638       638/938
(68 %)
23 diff
(97.6 %id)
BG034784 adenocarcinoma, cell line, Liver .b 2300 to 2953 1 to 645       645/931
(69 %)
18 diff
(98.1 %id)
BE907575 epithelioid carcinoma, Pancreas .b 2301 to 3005 1 to 704       704/736
(95 %)
7 diff
(99.1 %id)
BM769139 stomach .b 2304 to 2800 1 to 497       497/497
(100 %)
3 diff
(99.4 %id)
BM016709 astrocytoma grade IV, cell line, brain .b 2330 to 2486 1 to 156       156/156
(100 %)
2 diff
(98.8 %id)
BM020634 astrocytoma grade IV, cell line, brain .b 2331 to 2486 1 to 155       155/155
(100 %)
2 diff
(98.8 %id)
TI_59386870   .b 2332 to 2803 135 to 604       470/492
(95 %)
13 diff
(97.4 %id)
BX416123 neuroblastoma .b 2334 to 3348 1 to 1002       1002/1083
(92 %)
24 diff
(97.8 %id)
BF568339 epithelioid carcinoma cell line, Pancreas .b 2342 to 2486 1 to 143       143/143
(100 %)
3 diff
(98.0 %id)
BI159962 epithelioid carcinoma cell line, Pancreas .b 2342 to 2486 1 to 143       143/143
(100 %)
6 diff
(95.9 %id)
BM790659 stomach .b 2352 to 2962 1 to 610       610/610
(100 %)
3 diff
(99.6 %id)
BM791646 stomach .b 2352 to 2962 1 to 612       612/612
(100 %)
7 diff
(98.9 %id)
R61455 whole brain .b 2355 to 2822 1 to 471       471/473
(99 %)
24 diff
(95.0 %id)
BG751890 eye, normal pigmented retinal epithelium .b 2356 to 2486 1 to 131       131/131
(100 %)
2 diff
(98.5 %id)
BQ673075 epidermoid carcinoma, cell line, salivary gland .b 2360 to 3152 1 to 802       802/919
(87 %)
26 diff
(97.2 %id)
BG424129 Kidney, renal cell adenocarcinoma .b 2374 to 2486 1 to 112       112/112
(100 %)
2 diff
(98.3 %id)
BX331282 Neuroblastoma Cot 10-normalized .b 2384 to 2742 608 to 985       933/985
(94 %)
54 diff
(94.6 %id)
CF140296 CNCAP(3)T-225 cell line, Prostate .b 2393 to 2761 8 to 376       369/376
(98 %)
0 diff
(100 %id)
TI_154170684   .b 2393 to 3079 80 to 769       690/907
(76 %)
32 diff
(96.5 %id)
BX371358 Neuroblastoma Cot 10-normalized .b 2395 to 3330 928 to 1       928/929
(99 %)
21 diff
(97.8 %id)
CN391526 embryonic stem cells, cell lines H1, H7, andH9 .b 2413 to 3014 24 to 627       604/627
(96 %)
6 diff
(99.1 %id)
AA853352 Bone, Hip .b 2425 to 2558 8 to 139       132/139
(94 %)
2 diff
(98.6 %id)
BX331996 Neuroblastoma Cot 25-normalized .b 2434 to 3110 1 to 676       676/676
(100 %)
3 diff
(99.6 %id)
CX163729 human embryonic stem cells differentiated toan early endodermal cell type .b 2440 to 3267 19 to 846       828/846
(97 %)
6 diff
(99.3 %id)
CF134568 CNCAP(3)T-225 cell line, Prostate .b 2451 to 2779 8 to 336       329/336
(97 %)
2 diff
(99.5 %id)
TI_154162552   .b 2451 to 2792 79 to 420       342/1356
(25 %)
5 diff
(99.7 %id)
DR155947 human embryonic stem cells differentiated toan early endodermal cell type .b 2467 to 2780 1 to 314       314/325
(96 %)
1 diff
(99.7 %id)
BF342546 brain, glioblastoma with EGFR amplification .b 2476 to 3166 1 to 692       692/985
(70 %)
9 diff
(99.1 %id)
CN391520 embryonic stem cells, cell lines H1, H7, andH9 .b 2493 to 2947 465 to 11     Submitted on the opposite strand 455/465
(97 %)
0 diff
(100 %id)
T08803   .b 2511 to 2835 1 to 324       324/324
(100 %)
2 diff
(99.4 %id)
T08132   .b 2534 to 2681 1 to 148       148/150
(98 %)
3 diff
(98.0 %id)
BF314308 brain, neuroblastoma .b 2536 to 3195 1 to 655       655/655
(100 %)
14 diff
(97.9 %id)
BF316708 brain, neuroblastoma .b 2536 to 3249 1 to 694       694/921
(75 %)
24 diff
(97.4 %id)
BE383445 brain, neuroblastoma .b 2538 to 3228 49 to 747       699/847
(82 %)
42 diff
(95.1 %id)
CN391541 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2558 to 3063 1 to 506       506/506
(100 %)
1 diff
(99.9 %id)
BU189089 melanotic melanoma, cell line, skin .b 2605 to 3436 1 to 835       835/948
(88 %)
13 diff
(98.7 %id)
CD579778 brain .b 2666 to 3238 1 to 572       572/621
(92 %)
18 diff
(97.2 %id)
CN391529 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 2684 to 3181 1 to 498       498/498
(100 %)
1 diff
(99.8 %id)
BE791534 lung, small cell carcinoma .b 2720 to 3448 1 to 726       726/726
(100 %)
10 diff
(98.7 %id)
AL135572 melanoma (MeWo cell line) .b 2725 to 3132 1 to 405       405/408
(99 %)
16 diff
(96.1 %id)
BQ949181 large cell carcinoma, lung .b 2740 to 3639 1 to 910       910/916
(99 %)
19 diff
(98.0 %id)
CX756063 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 2744 to 3401 74 to 731     Submitted on the opposite strand 658/731
(90 %)
0 diff
(100 %id)
BF027297 melanotic melanoma, skin .b 2747 to 3561 33 to 837       805/853
(94 %)
6 diff
(99.3 %id)
BQ954166 large cell carcinoma, lung .b 2747 to 3680 1 to 950       950/962
(98 %)
47 diff
(95.2 %id)
BG104195 melanotic melanoma, skin .b 2754 to 3305 1 to 553       553/553
(100 %)
3 diff
(99.5 %id)
BG397113 melanotic melanoma, skin .b 2754 to 3561 1 to 814       814/915
(88 %)
35 diff
(96.2 %id)
BG251701 adenocarcinoma, cell line, Liver .b 2761 to 3453 1 to 685       685/685
(100 %)
15 diff
(97.9 %id)
AL041302 testis .b 2762 to 3016 1 to 257       257/258
(99 %)
5 diff
(98.1 %id)
BM740822 Ascites, stomach .b 2762 to 3378 1 to 617       617/617
(100 %)
0 diff
(100 %id)
BM772887 Ascites, stomach .b 2762 to 3385 1 to 624       624/624
(100 %)
0 diff
(100 %id)
BM759597 Ascites, stomach .b 2762 to 3354 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BM756071 Ascites, stomach .b 2762 to 3382 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BM756011 Ascites, stomach .b 2762 to 3230 1 to 469       469/469
(100 %)
0 diff
(100 %id)
BM737732 Ascites, stomach .b 2773 to 3344 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
BQ923880 eye, normal pigmented retinal epithelium .b 2782 to 3426 1 to 642       642/906
(70 %)
9 diff
(99.1 %id)
BQ218437 epithelioid carcinoma, Pancreas .b 2787 to 3395 1 to 614       614/889
(69 %)
28 diff
(96.9 %id)
BI457466 epithelioid carcinoma cell line, Pancreas .b 2794 to 3402 1 to 613       613/613
(100 %)
8 diff
(98.7 %id)
TI_45133721   .b 2795 to 3402 63 to 674       612/612
(100 %)
7 diff
(98.9 %id)
BG911890 anaplastic oligodendroglioma with 1p/19qloss, brain .b 2796 to 3395 1 to 613       613/747
(82 %)
33 diff
(95.6 %id)
BU839371 melanotic melanoma, cell line, skin .b 2797 to 3269 1 to 474       474/1271
(37 %)
13 diff
(99.0 %id)
BE391304 endometrium, adenocarcinoma cell line, uterus .b 2804 to 3417 1 to 617       617/617
(100 %)
8 diff
(98.8 %id)
BE277337 melanotic melanoma, skin .b 2806 to 3402 1 to 597       597/598
(99 %)
4 diff
(99.4 %id)
BE389137 endometrium, adenocarcinoma cell line, uterus .b 2808 to 3455 1 to 649       649/652
(99 %)
26 diff
(96.1 %id)
BQ711391 Spleen .b 2810 to 3439 1 to 632       632/1011
(62 %)
8 diff
(99.3 %id)
BE253133 eye, retinoblastoma .b 2819 to 2936 1 to 122       122/122
(100 %)
8 diff
(93.5 %id)
BE018922.
matches multiple genes
Kidney, renal cell adenocarcinoma .b 2824 to 3360 1 to 537     also hits gene GPC1 537/537
(100 %)
0 diff
(100 %id)
BQ676632 melanotic melanoma, cell line, skin .b 2828 to 3442 1 to 615       615/976
(63 %)
6 diff
(99.4 %id)
BI457254 epithelioid carcinoma cell line, Pancreas .b 2829 to 3547 1 to 719       719/719
(100 %)
28 diff
(96.2 %id)
BQ681661 melanotic melanoma, cell line, skin .b 2829 to 3639 17 to 832       816/935
(87 %)
14 diff
(98.6 %id)
TI_45133260   .b 2830 to 3547 55 to 772       718/718
(100 %)
27 diff
(96.3 %id)
BQ961917 epithelioid carcinoma cell line, Pancreas .b 2831 to 3589 1 to 767       767/943
(81 %)
16 diff
(98.4 %id)
BE312065 brain, neuroblastoma .b 2843 to 3370 1 to 532       532/535
(99 %)
14 diff
(97.4 %id)
BG751600 eye, normal pigmented retinal epithelium .b 2869 to 3518 1 to 671       671/671
(100 %)
33 diff
(95.1 %id)
BG748871 eye, normal pigmented retinal epithelium .b 2874 to 3651 1 to 780       780/782
(99 %)
20 diff
(97.5 %id)
BM128090 Islets of Langerhans, Pancreas .b 2874 to 3404 1 to 531   fully sequenced,   531/531
(100 %)
0 diff
(100 %id)
BF340118 brain, glioblastoma with EGFR amplification .b 2876 to 3238 293 to 674       593/674
(87 %)
36 diff
(94.7 %id)
CN391542 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 2888 to 3599 1 to 713       713/713
(100 %)
1 diff
(99.9 %id)
AA447165   .b 2906 to 3404 1 to 491       491/491
(100 %)
8 diff
(98.4 %id)
R31323 placenta .b 2931 to 3269 1 to 338       338/339
(99 %)
15 diff
(95.6 %id)
BX106669 placenta .b 2932 to 3760 1 to 830       830/830
(100 %)
6 diff
(99.3 %id)
AA092542   .b 2946 to 3103 15 to 166       152/166
(91 %)
6 diff
(96.4 %id)
BG389803 embryonal carcinoma, cell line, testis .b 2956 to 3568 1 to 605       605/605
(100 %)
31 diff
(94.9 %id)
BF204346 muscle, rhabdomyosarcoma .b 2975 to 3731 1 to 742       742/814
(91 %)
24 diff
(97.1 %id)
BG827929 muscle, rhabdomyosarcoma .b 2975 to 3808 1 to 839       839/839
(100 %)
24 diff
(97.2 %id)
CX756194 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 2981 to 3408 317 to 745     Submitted on the opposite strand 429/745
(57 %)
6 diff
(99.2 %id)
BQ669240 epidermoid carcinoma, cell line, salivary gland .b 2983 to 3739 1 to 762       762/920
(82 %)
24 diff
(97.4 %id)
BQ671838 epidermoid carcinoma, cell line, salivary gland .b 2983 to 3439 1 to 457       457/996
(45 %)
3 diff
(99.7 %id)
BU155083 melanotic melanoma, skin .b 2984 to 3652 1 to 679       679/929
(73 %)
22 diff
(97.7 %id)
BF344748 brain, glioblastoma with EGFR amplification .b 2991 to 3558 1 to 568       568/568
(100 %)
23 diff
(96.0 %id)
AW900113 nervous_normal .b 3005 to 3410 1 to 406       406/406
(100 %)
9 diff
(97.8 %id)
BQ638066 eye, retina .b 3007 to 3635 1 to 629       629/629
(100 %)
0 diff
(100 %id)
EL955318 eyeball .b 3021 to 3576 1 to 556       556/556
(100 %)
6 diff
(99.0 %id)
TI_154110519   .b 3021 to 3822 878 to 85   AAA   794/938
(84 %)
15 diff
(98.5 %id)
BE937825 testis_normal .b 3025 to 3284 42 to 301       260/308
(84 %)
8 diff
(97.5 %id)
BU161251 melanotic melanoma, skin .b 3030 to 3865 1 to 875       875/877
(99 %)
8 diff
(99.1 %id)
ES311448 frontal balding hair, skin .b 3033 to 3211 1 to 176       176/176
(100 %)
5 diff
(97.2 %id)
BX374576 Neuroblastoma Cot 10-normalized .b 3043 to 3810 783 to 1       783/786
(99 %)
14 diff
(98.3 %id)
BF343266 brain, glioblastoma with EGFR amplification .b 3046 to 3793 1 to 740       740/977
(75 %)
31 diff
(96.9 %id)
BG764212 melanotic melanoma, high MDR (cell line), skin .b 3048 to 3820 1 to 768       768/778
(98 %)
25 diff
(96.8 %id)
BG764956 melanotic melanoma, high MDR (cell line), skin .b 3048 to 3733 1 to 689       689/690
(99 %)
23 diff
(96.7 %id)
CN391537 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 3049 to 3623 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
BG766016 melanotic melanoma, high MDR (cell line), skin .b 3054 to 3720 1 to 676       676/679
(99 %)
28 diff
(95.9 %id)
BE781355 eye, retinoblastoma .b 3055 to 3742 1 to 721       721/1081
(66 %)
44 diff
(96.0 %id)
BM738392 Ascites, stomach .b 3059 to 3292 1 to 234       234/235
(99 %)
1 diff
(99.6 %id)
R47479   .b 3060 to 3196 155 to 22       134/155
(86 %)
0 diff
(100 %id)
N42367 melanocyte .b 3062 to 3255 14 to 206       193/206
(93 %)
6 diff
(97.1 %id)
BE004056 breast_normal .b 3069 to 3326 271 to 14     Submitted on the opposite strand 258/272
(94 %)
0 diff
(100 %id)
BM713637 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3082 to 3606 1 to 525       525/525
(100 %)
0 diff
(100 %id)
N78076 liver and spleen .b 3091 to 3443 1 to 352       352/352
(100 %)
21 diff
(94.1 %id)
BM743967 Ascites, stomach .b 3107 to 3220 1 to 114       114/114
(100 %)
0 diff
(100 %id)
BI195453 brain, neuroblastoma .b 3122 to 3611 7 to 482       476/562
(84 %)
34 diff
(94.0 %id)
CA306474 Alveolar Macrophage, lung .b 3130 to 3822 711 to 19   AAA   693/693
(100 %)
5 diff
(99.3 %id)
BX404565 neuroblastoma .b 3142 to 4096 945 to 1       945/1019
(92 %)
16 diff
(98.5 %id)
TI_57242761   .b 3155 to 3853 66 to 778       713/798
(89 %)
28 diff
(96.5 %id)
BI914133 brain .b 3162 to 3853 1 to 706       706/726
(97 %)
26 diff
(96.5 %id)
BF509090   .b 3186 to 3822 654 to 18   AAA   637/637
(100 %)
3 diff
(99.6 %id)
BQ017409 lung, Metastatic Chondrosarcoma .b 3190 to 3822 649 to 19   AAA   631/631
(100 %)
3 diff
(99.6 %id)
W60770 heart .b 3193 to 3576 1 to 386       386/386
(100 %)
3 diff
(99.3 %id)
BG576847 breast, mammary adenocarcinoma, cell line .b 3205 to 3809 1 to 609       609/609
(100 %)
18 diff
(97.1 %id)
R46428 breast .b 3219 to 3449 1 to 231       231/231
(100 %)
1 diff
(99.6 %id)
BF340108 brain, glioblastoma with EGFR amplification .b 3220 to 3850 1 to 626       626/626
(100 %)
12 diff
(98.1 %id)
TI_154060988   .b 3221 to 3822 701 to 100   AAA   602/975
(61 %)
7 diff
(99.3 %id)
CA420348 Bone, Enchondroma cell line .b 3221 to 3822 620 to 19   AAA   602/605
(99 %)
7 diff
(98.9 %id)
CF126772 Chondrosarcoma Lung Metastasis cell lines, lung .b 3223 to 3938 1 to 716   tiling clone,   716/716
(100 %)
1 diff
(99.9 %id)
TI_154189820   .b 3223 to 4048 51 to 873       823/1018
(80 %)
9 diff
(99.2 %id)
CN391533 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 3234 to 3419 1 to 185       185/185
(100 %)
1 diff
(99.5 %id)
BM729134 eye, fetal eye .b 3241 to 3523 190 to 472   fully sequenced,   283/472
(59 %)
5 diff
(99.0 %id)
BG385418 adenocarcinoma cell line, colon .b 3265 to 3681 1 to 424       424/427
(99 %)
9 diff
(97.9 %id)
TI_149281742   .b 3265 to 3733 71 to 538   AAA Submitted on the opposite strand 468/807
(57 %)
7 diff
(99.2 %id)
CD674112 eye, lens .b 3277 to 3825 565 to 17   AAA   549/549
(100 %)
0 diff
(100 %id)
BU679693 lung .b 3277 to 3733 13 to 468   AAA Submitted on the opposite strand 456/476
(95 %)
2 diff
(99.6 %id)
BQ219383 epithelioid carcinoma, Pancreas .b 3289 to 3958 1 to 677       677/961
(70 %)
41 diff
(95.8 %id)
BM050068 epithelioid carcinoma cell line, Pancreas .b 3290 to 3826 1 to 540       540/804
(67 %)
11 diff
(98.7 %id)
TI_159724135   .b 3349 to 4128 856 to 86   AAA   771/966
(79 %)
17 diff
(98.3 %id)
BM069867 Islets of Langerhans, Pancreas .b 3379 to 3650 1 to 273   fully sequenced,   273/273
(100 %)
11 diff
(96.0 %id)
BM127814 Islets of Langerhans, Pancreas .b 3380 to 3822 448 to 5   fully sequenced,   444/448
(99 %)
0 diff
(100 %id)
AI934753 anaplastic oligodendroglioma, brain .b 3381 to 3822 444 to 3       442/444
(99 %)
0 diff
(100 %id)
BQ008105 Chondrosarcoma, Left Pelvis .b 3383 to 4128 753 to 19   AAA   735/735
(100 %)
13 diff
(98.3 %id)
AI581296   .b 3386 to 3825 450 to 11   AAA   440/440
(100 %)
0 diff
(100 %id)
BG818789 anaplastic oligodendroglioma with 1p/19qloss, brain .b 3388 to 4134 1 to 738       738/847
(87 %)
25 diff
(97.1 %id)
BU846206 ovary, teratocarcinoma, cell line .b 3389 to 3822 35 to 466   AAA   432/466
(92 %)
6 diff
(98.8 %id)
BF569128 epithelioid carcinoma cell line, Pancreas .b 3392 to 4070 718 to 9       710/1224
(58 %)
0 diff
(100 %id)
AW295876   .b 3394 to 3822 446 to 18   AAA   429/429
(100 %)
0 diff
(100 %id)
AI590648 ovary, tumor, 5 pooled (see description) .b 3404 to 3822 419 to 1       419/419
(100 %)
0 diff
(100 %id)
CA426761 cell lines, Chondrosarcoma .b 3408 to 4128 739 to 19   AAA   721/721
(100 %)
4 diff
(99.5 %id)
TI_154030616   .b 3418 to 3784 440 to 73       368/441
(83 %)
0 diff
(100 %id)
BU154087 eye, retinoblastoma .b 3425 to 4036 1 to 618       618/922
(67 %)
20 diff
(97.9 %id)
BG250368 adenocarcinoma, cell line, Liver .b 3438 to 3918 1 to 489       489/952
(51 %)
28 diff
(97.1 %id)
CA442574 lung, Lung Focal Fibrosis .b 3438 to 3790 376 to 23   AAA   354/354
(100 %)
6 diff
(98.4 %id)
TI_149292562   .b 3440 to 4128 772 to 86   AAA   687/690
(99 %)
4 diff
(99.5 %id)
BX438103 neuroblastoma .b 3447 to 4111 665 to 1       665/665
(100 %)
20 diff
(97.0 %id)
AW296260   .b 3453 to 3822 387 to 18   AAA   370/370
(100 %)
0 diff
(100 %id)
BX331995 Neuroblastoma Cot 25-normalized .b 3454 to 4112 657 to 1       657/657
(100 %)
19 diff
(97.2 %id)
TI_151779968   .b 3454 to 4131 78 to 759       682/962
(70 %)
40 diff
(95.9 %id)
BM675108 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 3455 to 4128 691 to 19   AAA   673/674
(99 %)
1 diff
(99.9 %id)
BM974644 lung .b 3463 to 4128 684 to 19   AAA   666/669
(99 %)
1 diff
(99.9 %id)
CA944796 Human Lung Epithelial cells, lung .b 3470 to 4128 679 to 19   AAA   661/661
(100 %)
3 diff
(99.6 %id)
AI472781 pooled .b 3480 to 3825 356 to 11   AAA   346/346
(100 %)
0 diff
(100 %id)
BQ019691 Chondrosarcoma, Left Pubic Bone .b 3485 to 4128 664 to 19   AAA   646/646
(100 %)
2 diff
(99.7 %id)
BM467972 leiomyosarcoma, uterus .b 3487 to 4130 1 to 644   tiling clone,   644/648
(99 %)
1 diff
(99.9 %id)
BM682062 eye, fetal eye .b 3493 to 4128 653 to 19   fully sequenced, AAA   635/635
(100 %)
1 diff
(99.9 %id)
BQ888904 melanotic melanoma, cell line, skin .b 3500 to 4128 5 to 633   AAA   629/633
(99 %)
7 diff
(98.9 %id)
AW613261 colon, moderately-differentiated adenocarcinoma .b 3515 to 3822 310 to 3       308/310
(99 %)
0 diff
(100 %id)
AW085565 pooled .b 3519 to 3822 308 to 5       304/308
(98 %)
0 diff
(100 %id)
AA639605 colon, colon tumor RER+ .b 3520 to 3821 302 to 1       302/302
(100 %)
0 diff
(100 %id)
N58487 liver and spleen .b 3525 to 4122 601 to 1       601/601
(100 %)
11 diff
(98.2 %id)
D31273   .b 3529 to 3838 1 to 310       310/310
(100 %)
1 diff
(99.7 %id)
D31339   .b 3529 to 3853 1 to 327       327/330
(99 %)
5 diff
(98.5 %id)
T98157 liver and spleen .b 3537 to 3818 10 to 290   fully sequenced,   281/290
(96 %)
7 diff
(97.6 %id)
R00910 liver and spleen .b 3538 to 3856 1 to 326   fully sequenced,   326/326
(100 %)
4 diff
(98.8 %id)
TI_157606881   .b 3538 to 4128 679 to 91   AAA   589/740
(79 %)
15 diff
(98.0 %id)
R08451 liver and spleen .b 3540 to 3819 1 to 281       281/281
(100 %)
7 diff
(97.6 %id)
N31712.
matches multiple genes
melanocyte .b 3543 to 4129 589 to 1     also hits gene VEGFC 589/589
(100 %)
3 diff
(99.5 %id)
AI091558 pooled .b 3562 to 3822 265 to 5       261/265
(98 %)
0 diff
(100 %id)
BF196336 fibrotheoma, ovary .b 3562 to 4128 567 to 1       567/567
(100 %)
1 diff
(99.9 %id)
BE858133 brain, glioblastoma (pooled) .b 3572 to 4121 550 to 1       550/550
(100 %)
0 diff
(100 %id)
CD369343 Alveolar Macrophage, lung .b 3572 to 4128 571 to 16   AAA   556/556
(100 %)
1 diff
(99.9 %id)
TI_151753509   .b 3591 to 4130 651 to 108       544/654
(83 %)
0 diff
(100 %id)
AI678346 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3602 to 4128 515 to 1       515/526
(97 %)
11 diff
(98.0 %id)
BU740007 eye, fetal eye .b 3619 to 4128 527 to 19   AAA   509/509
(100 %)
2 diff
(99.7 %id)
BM069616 Islets of Langerhans, Pancreas .b 3620 to 4070 468 to 18   fully sequenced, AAA   451/451
(100 %)
1 diff
(99.8 %id)
BP397946 pancreatic islet .b 3622 to 4121 1 to 500     Submitted on the opposite strand 500/500
(100 %)
0 diff
(100 %id)
BP394585 pancreatic islet .b 3633 to 4130 1 to 498     Submitted on the opposite strand 498/500
(99 %)
1 diff
(99.8 %id)
BE294923 muscle, rhabdomyosarcoma .b 3636 to 4121 1 to 487       487/675
(72 %)
6 diff
(99.2 %id)
W60708 heart .b 3640 to 4129 498 to 1       498/498
(100 %)
11 diff
(97.8 %id)
AI741189 pooled .b 3655 to 4130 482 to 6       477/482
(98 %)
0 diff
(100 %id)
AI819260 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 3658 to 4130 477 to 4       474/477
(99 %)
0 diff
(100 %id)
AW149500 brain, medulloblastoma .b 3658 to 4130 473 to 1       473/473
(100 %)
1 diff
(99.8 %id)
AW771072 colon, juvenile granulosa tumor .b 3658 to 4109 453 to 1       453/453
(100 %)
3 diff
(99.4 %id)
AI797840 B-cell, chronic lymphotic leukemia .b 3659 to 4130 472 to 1       472/472
(100 %)
0 diff
(100 %id)
AI816927 2 pooled tumors (clear cell type), Kidney .b 3659 to 4130 474 to 3       472/474
(99 %)
0 diff
(100 %id)
AI693960 colon .b 3668 to 4128 461 to 1       461/461
(100 %)
3 diff
(99.4 %id)
AI094419 brain, glioblastoma (pooled) .b 3673 to 4129 455 to 1       455/455
(100 %)
3 diff
(99.4 %id)
AW409925 muscle, rhabdomyosarcoma .b 3676 to 4128 486 to 34   AAA   453/453
(100 %)
23 diff
(95.0 %id)
BE349341 malignant melanoma, metastatic to lymphnode, skin .b 3677 to 4128 462 to 11   AAA   452/452
(100 %)
0 diff
(100 %id)
AI827378 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3678 to 4121 473 to 29   AAA   445/445
(100 %)
1 diff
(99.8 %id)
CX873226 embryonic stem .b 3682 to 4022 1 to 339   AAA   339/355
(95 %)
3 diff
(99.2 %id)
BG167410 hypernephroma, cell line, Kidney .b 3684 to 4128 1 to 446   AAA   446/446
(100 %)
3 diff
(99.4 %id)
BG169222 hypernephroma, cell line, Kidney .b 3685 to 4129 1 to 442   AAA   442/442
(100 %)
8 diff
(98.2 %id)
AI031621 brain, glioblastoma (pooled) .b 3691 to 4129 440 to 1       440/440
(100 %)
1 diff
(99.8 %id)
AI924337 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 3694 to 4120 429 to 3       427/429
(99 %)
0 diff
(100 %id)
AI298291 carcinoid, lung .b 3697 to 4130 435 to 2       434/435
(99 %)
0 diff
(100 %id)
BG168664 hypernephroma, cell line, Kidney .b 3697 to 4130 1 to 434       434/466
(93 %)
4 diff
(99.2 %id)
AI890661 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3699 to 4130 433 to 1       433/433
(100 %)
3 diff
(99.4 %id)
AI434580 lymph node, lymphoma, follicular mixed small and largecell .b 3701 to 4128 428 to 1       428/428
(100 %)
0 diff
(100 %id)
BI062314 uterus_tumor .b 3703 to 3911 1 to 209       209/209
(100 %)
3 diff
(98.6 %id)
AA443793   .b 3707 to 4130 425 to 2       424/425
(99 %)
0 diff
(100 %id)
AW104232 pooled .b 3715 to 4129 421 to 1       421/444
(94 %)
12 diff
(97.3 %id)
BF213160 bone marrow, from acute myelogenous leukemia .b 3716 to 4126 1 to 405       405/442
(91 %)
7 diff
(98.5 %id)
BF691880 melanotic melanoma, high MDR, skin .b 3716 to 4128 1 to 413       413/715
(57 %)
9 diff
(98.8 %id)
DB546635 hippocampus .b 3719 to 4128 1 to 410     Submitted on the opposite strand 410/410
(100 %)
0 diff
(100 %id)
AW631028 2 pooled high-grade transitional celltumors, genitourinary tract .b 3720 to 4078 1 to 359       359/359
(100 %)
7 diff
(98.1 %id)
AI689288 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 3722 to 4130 409 to 1       409/409
(100 %)
3 diff
(99.3 %id)
AI393142 pooled .b 3727 to 4130 406 to 4       403/406
(99 %)
0 diff
(100 %id)
AI761653 B-cell, chronic lymphotic leukemia .b 3727 to 4120 394 to 1       394/394
(100 %)
0 diff
(100 %id)
AI061351   .b 3728 to 4130 407 to 5       403/407
(99 %)
0 diff
(100 %id)
AI032061 liver and spleen .b 3729 to 4121 393 to 1       393/393
(100 %)
1 diff
(99.8 %id)
AW572369 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3729 to 4130 403 to 2       402/403
(99 %)
0 diff
(100 %id)
AW072975 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .b 3730 to 4128 399 to 1       399/399
(100 %)
2 diff
(99.5 %id)
AI310105 2 pooled tumors (clear cell type), Kidney .b 3731 to 4130 401 to 2       400/401
(99 %)
0 diff
(100 %id)
D12114 Liver .b 3739 to 4121 1 to 397       397/427
(92 %)
4 diff
(99.1 %id)
BG056563 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .b 3743 to 4128 414 to 21   AAA   394/402
(98 %)
9 diff
(97.8 %id)
CB145754 Liver .b 3747 to 4130 423 to 41     Submitted on the opposite strand 383/427
(89 %)
0 diff
(100 %id)
AI913605 Kidney .b 3755 to 4128 374 to 1       374/374
(100 %)
0 diff
(100 %id)
AA617780 lung, lung tumor .b 3757 to 4128 391 to 20   AAA   372/372
(100 %)
1 diff
(99.8 %id)
AA090556   .b 3774 to 3844 1 to 71       71/71
(100 %)
0 diff
(100 %id)
AA524221 colon .b 3775 to 4129 355 to 1       355/364
(97 %)
0 diff
(100 %id)
AA661620 normal prostate, Prostate .b 3781 to 4057 277 to 1       277/277
(100 %)
1 diff
(99.7 %id)
AI623926 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3782 to 4130 353 to 5       349/353
(98 %)
0 diff
(100 %id)
AI339277 pooled germ cell tumors .b 3786 to 4128 366 to 24   AAA   343/343
(100 %)
5 diff
(98.6 %id)
T98158 liver and spleen .b 3788 to 4131 354 to 1   fully sequenced,   354/354
(100 %)
11 diff
(96.9 %id)
AI583157 adenocarcinoma, Pancreas .b 3790 to 4130 348 to 8       341/348
(97 %)
0 diff
(100 %id)
AI453676 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3791 to 4128 336 to 1       336/336
(100 %)
3 diff
(99.2 %id)
AI472597 pooled .b 3791 to 4045 257 to 1       257/257
(100 %)
2 diff
(99.3 %id)
BG030864 breast, mammary adenocarcinoma, cell line .b 3795 to 4121 27 to 349   AAA   323/349
(92 %)
6 diff
(98.3 %id)
AA196520   .b 3796 to 4130 336 to 2       335/336
(99 %)
0 diff
(100 %id)
AI024132   .b 3796 to 4130 336 to 2       335/336
(99 %)
0 diff
(100 %id)
AA513345 colon .b 3805 to 4121 317 to 1       317/317
(100 %)
0 diff
(100 %id)
BF589666 Prostate .b 3805 to 4128 324 to 1       324/324
(100 %)
3 diff
(99.1 %id)
AI016034 Kidney .b 3808 to 4128 321 to 1       321/321
(100 %)
0 diff
(100 %id)
AW779899 Kidney .b 3810 to 4114 314 to 10       305/314
(97 %)
0 diff
(100 %id)
AA813380   .b 3816 to 4130 316 to 2       315/316
(99 %)
0 diff
(100 %id)
BU193138 epithelioid carcinoma, Pancreas .b 3819 to 4128 32 to 340   AAA   309/340
(90 %)
6 diff
(98.3 %id)
BQ084181 stomach .b 3822 to 4087 1 to 267       267/267
(100 %)
2 diff
(99.3 %id)
BG056923 anaplastic oligodendroglioma, brain .b 3823 to 4129 307 to 1       307/307
(100 %)
2 diff
(99.4 %id)
CB105378 Liver .b 3823 to 4126 1 to 304       304/304
(100 %)
0 diff
(100 %id)
R02150 liver and spleen .b 3826 to 4131 313 to 1   fully sequenced,   313/313
(100 %)
6 diff
(98.1 %id)
R08452 liver and spleen .b 3826 to 4123 308 to 2       307/314
(97 %)
0 diff
(100 %id)
R58936   .b 3829 to 4128 299 to 1       299/310
(96 %)
4 diff
(98.8 %id)
AI282095 2 pooled tumors (clear cell type), Kidney .b 3841 to 4130 292 to 3       290/292
(99 %)
0 diff
(100 %id)
AA746071 Kidney .b 3842 to 4129 288 to 1       288/288
(100 %)
1 diff
(99.7 %id)
BP397057 pancreatic islet .b 3847 to 4123 1 to 277     Submitted on the opposite strand 277/277
(100 %)
1 diff
(99.7 %id)
AW028510 Kidney .b 3850 to 4133 297 to 14   AAA   284/284
(100 %)
4 diff
(98.6 %id)
AA470871 colon .b 3854 to 4128 277 to 1       277/277
(100 %)
3 diff
(99.0 %id)
BE677256 dorsal root ganglia .b 3859 to 4130 273 to 2       272/273
(99 %)
0 diff
(100 %id)
AI817106 lymph node, lymphoma, follicular mixed small and largecell .b 3873 to 4130 263 to 6       258/263
(98 %)
0 diff
(100 %id)
R42522 whole brain .b 3898 to 4128 248 to 18   AAA   231/231
(100 %)
1 diff
(99.6 %id)
BM145136 leukopheresis .b 3900 to 4121 248 to 27   AAA   222/222
(100 %)
10 diff
(95.5 %id)
AI873752 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 3908 to 4126 266 to 48       219/266
(82 %)
0 diff
(100 %id)
AW026023 Kidney .b 3916 to 4126 215 to 4       212/215
(98 %)
0 diff
(100 %id)
BE327788 malignant melanoma, metastatic to lymphnode, skin .b 3965 to 4129 165 to 1       165/165
(100 %)
0 diff
(100 %id)
AA853351 Bone, Hip .b 3974 to 4082 112 to 4       109/112
(97 %)
0 diff
(100 %id)
R31582 placenta .b 3988 to 4118 131 to 1       131/131
(100 %)
0 diff
(100 %id)
AI824234 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .b 3992 to 4127 136 to 1       136/136
(100 %)
3 diff
(97.8 %id)
AA995486 germ cell tumor .b 4000 to 4128 170 to 42   AAA   129/129
(100 %)
0 diff
(100 %id)
AA861918   .b 4006 to 4130 131 to 7       125/141
(88 %)
0 diff
(100 %id)
GD157328   .b 4015 to 4105 91 to 1     Submitted on the opposite strand 91/108
(84 %)
2 diff
(98.2 %id)
GD157431   .b 4015 to 4105 90 to 1     Submitted on the opposite strand 90/92
(97 %)
4 diff
(95.7 %id)
AI885887 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 4031 to 4098 1 to 68   AAA Submitted on the opposite strand 68/68
(100 %)
4 diff
(94.2 %id)
GD149970   .b 4034 to 4105 72 to 1     Submitted on the opposite strand 72/78
(92 %)
2 diff
(97.5 %id)
BE536577 cervix .c 1 to 587 1 to 595   tiling clone,   595/595
(100 %)
17 diff
(97.2 %id)
BE263005 brain, neuroblastoma .c 182 to 856 16 to 688   tiling clone,   673/690
(97 %)
12 diff
(98.3 %id)
BF312891 brain, neuroblastoma .c 186 to 898 1 to 702   tiling clone,   702/844
(83 %)
21 diff
(97.6 %id)
BF872456 lung_tumor .d-u 1 to 546 569 to 22 P104S V105S H106T L107P Q108P ... tiling clone, AAA Submitted on the opposite strand 548/551
(99 %)
14 diff
(97.5 %id)
CV366247 ovary .d-u 102 to 304 1 to 199       199/199
(100 %)
5 diff
(97.5 %id)
CK000957 mixed .e 1 to 745 8 to 742 S89T W90G L91C C92V P93R ... tiling clone,   735/788
(93 %)
12 diff
(98.5 %id)
CK000672 mixed .e 1 to 743 8 to 750 A82T T104N tiling clone,   743/799
(92 %)
9 diff
(98.9 %id)
BF920121 nervous_tumor .f-u 1 to 418 56 to 467 A13V G14M G15L T16A A17R ... tiling clone,   412/467
(88 %)
6 diff
(98.8 %id)
BM678809 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene TTYH3, variant not shown       fully sequenced, AAA Suspected internal deletion, this clone was ignored    
BM720530 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene TTYH3, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BM718551 eye, fetal eye Gene TTYH3, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BU742995 eye, fetal eye Gene TTYH3, variant not shown       fully sequenced, AAA Suspected internal deletion, this clone was ignored    
DA884630   Gene TTYH3, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB330416   Gene TTYH3, variant not shown         Suspected internal deletion, this clone was ignored    
AK124608 cerebellum Gene TTYH3, variant not shown       available from FLJ, This clone was ignored    
DB324336   Gene TTYH3, variant not shown         This clone was ignored    
DA724612   Gene TTYH3, variant not shown       capped This clone was ignored    
CN391515 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene TTYH3, variant not shown         Suspected internal deletion, this clone was ignored    
CN391540 embryonic stem cells, DMSO-treated H9 cellline Gene TTYH3, variant not shown         Suspected internal deletion, this clone was ignored    
DB318319   Gene TTYH3, variant not shown         Suspected internal deletion, this clone was ignored    
DA551266   Gene TTYH3, variant not shown       capped Suspected internal deletion, this clone was ignored    
AK096851   Gene TTYH3, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
DB299226 cerebellum Gene TTYH3, variant not shown         This clone was ignored    
DA102276 cerebellum Gene TTYH3, variant not shown       capped This clone was ignored    
N70795 lung Gene TTYH3, variant not shown         This clone was ignored    
W01411 lung Gene TTYH3, variant not shown         This clone was ignored    
AW081058 colon, moderately differentiated adenocarcinoma Gene TTYH3, variant not shown         This clone was ignored    
BE314172 brain, neuroblastoma Gene TTYH3, variant not shown         This clone was ignored    
BG519541 brain, neuroblastoma Gene TTYH3, variant not shown         Suspected internal deletion, this clone was ignored    
BF310705 brain, neuroblastoma Gene TTYH3, variant not shown         Suspected internal deletion, this clone was ignored    
DB325653 brain Gene TTYH3, variant not shown         This clone was ignored    
DA769397 brain Gene TTYH3, variant not shown       capped This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI